Tag: Covaxin

These findings have an important implication for the COVID-19 vaccination program wherein heterologous immunisation will pave the way for induction of improved and better protection against the variant strains of SARS-CoV-2.

The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission'.

Delta Plus is a mutated form of the Delta variant and was first discovered in India. It is characterised by increased transmissibility and spike protein mutations.

The Hyderabad-based company had said in May that that application for EUL was submitted to WHO-Geneva and regulatory approvals are expected by July-September 2021.

The State Health Department of Odisha has requested the Centre to allocate the balance Covid vaccine doses under private hospitals share to the State government.

The State government of Odisha on Friday announced to introduce Covaxin for inoculation of people aged 18 years and above in the district of Ganjam. Manufactured by the Bharat Biotech will be soon rolled out for vaccinating people in Ganjam district including the Berhampur Municipal Corporation area from the month of July.

A day after Odisha government curtailed the mass vaccination programme in the State in the wake of acute shortage of doses, around 9.43 lakh jabs of Covishield vaccines manufactured by the Serum Institute of India reached the State on Friday.

India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US' National Institute of Health has said.

The COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) on Tuesday reviewed the data and accepted it. Their recommendations have been sent to the DCGI now, a source said.

The State Health Department of Odisha has appealed to the people to take Covid-19 vaccine shot as early as possible and adhere to the appropriate Covid protocols ahead of a possible third wave of the pandemic that has already hit other countries.

As per experts, a vaccine will be considered a marathoner protector if it is able to produce good spike protein antibodies. A spike protein antibody test can confirm whether claims made by Covisheild and Covaxin are true

PETA wrote a letter on Thursday morning to DCGI's Dr V.G. Somani, to direct vaccine manufacturers, to consider its proposal following report that Covaxin uses NBCS during the production stage, which is extracted from the blood of slaughtered calves under 20 days old.

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.

The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, Bharat Biotech said on Tuesday.

The FDA had on Thursday recommended Ocugen, the US partner of the Indian vaccine maker, to "pursue a Biologics Licence Application (BLA) submission instead of an EUA application" and "requested additional information and data".